APA (7th ed.) Citation

Feuerecker, B., Tauber, R., Knorr, K., Heck, M., Beheshti, A., Seidl, C., . . . Eiber, M. (2021). Activity and adverse events of actinium-225-PSMA-617 in advanced metastatic castration-resistant prostate cancer after failure of lutetium-177-PSMA. European urology, 79(3), . https://doi.org/10.1016/j.eururo.2020.11.013

Chicago Style (17th ed.) Citation

Feuerecker, Benedikt, et al. "Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA." European Urology 79, no. 3 (2021). https://doi.org/10.1016/j.eururo.2020.11.013.

MLA (9th ed.) Citation

Feuerecker, Benedikt, et al. "Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA." European Urology, vol. 79, no. 3, 2021, https://doi.org/10.1016/j.eururo.2020.11.013.